scholarly article | Q13442814 |
P50 | author | Paul D Losty | Q89944464 |
David G. Fernig | Q37379493 | ||
P2093 | author name string | Toin H van Kuppevelt | |
Els M A van de Westerlo | |||
Jeremy E Turnbull | |||
Edwin C Jesudason | |||
Sophie M Thompson | |||
P2860 | cites work | Conformational transitions induced in heparin octasaccharides by binding with antithrombin III. | Q38312109 |
Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models | Q38335704 | ||
Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate | Q38338357 | ||
Interaction of heparin and antithrombin III. The role of O-sulfate groups | Q38346378 | ||
The antigenic determinants recognized by three monoclonal antibodies to keratan sulphate involve sulphated hepta- or larger oligosaccharides of the poly(N-acetyllactosamine) series | Q38350888 | ||
Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics | Q38353005 | ||
Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label | Q40679346 | ||
Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region | Q41777711 | ||
Molecular organization of heparan sulphate from human skin fibroblasts | Q41975008 | ||
Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure | Q42161980 | ||
Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates | Q42165347 | ||
Differential Expression of Heparan Sulfate Domains in Rat Spleen | Q42441475 | ||
Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: a study in developing mouse intercostal muscle | Q42525353 | ||
A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. | Q42809853 | ||
Highly sensitive sequencing of the sulfated domains of heparan sulfate. | Q42814375 | ||
Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of fibroblast heparan sulphate | Q42855547 | ||
Production and characterization of a monoclonal antibody against human glomerular heparan sulfate | Q43568073 | ||
Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. | Q43640409 | ||
Immunochemical characterization and ultrastructural localization of chondroitin sulfates and keratan sulfate in embryonic chick bone marrow | Q44237672 | ||
Epitope-specific changes in chondroitin sulfate/dermatan sulfate proteoglycans as markers in the lymphopoietic and granulopoietic compartments of developing bursae of Fabricius. | Q44244944 | ||
Identification of monoclonal antibodies that recognize novel epitopes in native chondroitin/dermatan sulfate glycosaminoglycan chains: their use in mapping functionally distinct domains of human skin | Q44510807 | ||
A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. | Q44816865 | ||
Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. | Q50975134 | ||
Immunocytochemical identification of basic fibroblast growth factor in the developing rat mammary gland: variations in location are dependent on glandular structure and differentiation | Q52224968 | ||
Effect of substitution pattern on 1 H, 13 C NMR chemical shifts and 1 J CH coupling constants in heparin derivatives | Q56833711 | ||
1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives | Q56833717 | ||
Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma | Q56895314 | ||
Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies | Q56895736 | ||
Chondroitin sulphate proteoglycans in extracellular matrices: sulphation specificity in relation to cellular differentiation | Q57540008 | ||
Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues | Q57540011 | ||
Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate. Monoclonal antibodies to cartilage proteoglycan | Q57540014 | ||
Liver heparan sulfate structure. A novel molecular design | Q64146700 | ||
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats | Q68136806 | ||
Endothelial heparan sulphate: compositional analysis and comparison of chains from different proteoglycan populations | Q68407274 | ||
Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain | Q72326632 | ||
N.m.r. and molecular-modelling studies of the solution conformation of heparin | Q24528140 | ||
Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species | Q24530061 | ||
The heparanome and regulation of cell function: structures, functions and challenges | Q28281711 | ||
Conformer populations of L-iduronic acid residues in glycosaminoglycan sequences | Q28283247 | ||
Conformation of heparin pentasaccharide bound to antithrombin III | Q28360842 | ||
Sequencing complex polysaccharides | Q30791276 | ||
Human single chain antibodies against heparin: selection, characterization, and effect on coagulation | Q30827306 | ||
Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. | Q30872188 | ||
Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening | Q31034506 | ||
Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney | Q32064386 | ||
Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides | Q33179207 | ||
Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site | Q33181061 | ||
Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. | Q33213182 | ||
3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. | Q33230192 | ||
Novel 'phage display antibodies identify distinct heparan sulfate domains in developing mammalian lung | Q33268875 | ||
Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. | Q33285352 | ||
Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures | Q33299802 | ||
Saccharide microarrays for high-throughput interrogation of glycan-protein binding interactions | Q33416890 | ||
Conformation and dynamics of heparin and heparan sulfate | Q34087654 | ||
Computer modeling of electrostatic steering and orientational effects in antibody-antigen association | Q34128635 | ||
A strategy for rapid sequencing of heparan sulfate and heparin saccharides | Q35059120 | ||
Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches | Q35626646 | ||
Heparan sulfates in skeletal muscle development and physiology | Q36180874 | ||
Evaluation of critical groups required for the binding of heparin to antithrombin | Q36248809 | ||
Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly | Q36324847 | ||
Multiprotein signalling complexes: regional assembly on heparan sulphate | Q36482130 | ||
Developmental changes in heparan sulfate expression: in situ detection with mAbs | Q36532134 | ||
Interactions between heparan sulfate and proteins: the concept of specificity | Q36552851 | ||
Structure of the antithrombin-binding site in heparin | Q37335850 | ||
Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue | Q38289147 | ||
High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions. | Q38304327 | ||
P433 | issue | 51 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phage display | Q896217 |
antibody | Q79460 | ||
P304 | page(s) | 35621-35631 | |
P577 | publication date | 2009-12-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities | |
P478 | volume | 284 |
Q58083847 | A mutant-cell library for systematic analysis of heparan sulfate structure-function relationships |
Q33824892 | A peptide found by phage display discriminates a specific structure of a trisaccharide in heparin. |
Q36481630 | An introduction to proteoglycans and their localization |
Q28484366 | Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide |
Q88721158 | Deep Sequencing of Complex Proteoglycans: A Novel Strategy for High Coverage and Site-specific Identification of Glycosaminoglycan-linked Peptides |
Q36332838 | Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. |
Q39549002 | Epac1 promotes melanoma metastasis via modification of heparan sulfate. |
Q35036977 | Glycobiology and the growth plate: current concepts in multiple hereditary exostoses |
Q38184451 | Growth factor-heparan sulfate "switches" regulating stages of branching morphogenesis |
Q99555914 | Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity |
Q35624698 | Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding. |
Q37151121 | Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation |
Q37698254 | Heparin sensing: blue-chip binding |
Q90722417 | Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions |
Q35224567 | Integrin-dependent and -independent functions of astrocytic fibronectin in retinal angiogenesis. |
Q37036808 | Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in mice |
Q38081956 | New targets for glycosaminoglycans and glycosaminoglycans as novel targets. |
Q36176861 | Poly(ethylene glycol acrylate)-functionalized hydrogels for heparan sulfate oligosaccharide recognition |
Q35656129 | SPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies. |
Q34071237 | Specific sides to multifaceted glycosaminoglycans are observed in embryonic development |
Q33932177 | Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation? |
Q28550135 | Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions |
Q34029195 | The heparan sulfate co-receptor and the concentration of fibroblast growth factor-2 independently elicit different signalling patterns from the fibroblast growth factor receptor |
Q34412830 | The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. |
Search more.